A retrospective study to assess the risk of bladder cancer in type-2 diabetic patients treated with pioglitazone

A retrospective study to assess the risk of bladder cancer in type-2 diabetic patients treated with pioglitazone

Introduction: Pioglitazone has been a cornerstone of oral hypoglycemic therapy. Concerns have been raised about its association with urinary bladder cancer. Considering the wide usage of this drug, concrete and multiple population-based studies are needed to establish the safety of this drug. The pr...

Full description

Bibliographic Details
Main Authors: Prabhat Agrawal, Apoorva Jain, Ashish Gautam, Ashwini Kumar Nigam, Nikhil Pursnani, Maaz Farooqui
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Perspectives in Clinical Research
Subjects:
adverse drug reaction
diabetes
oral hypoglycemic
pioglitazone
urinary bladder cancer
Online Access:http://www.picronline.org/article.asp?issn=2229-3485;year=2021;volume=12;issue=1;spage=9;epage=13;aulast=

Internet

http://www.picronline.org/article.asp?issn=2229-3485;year=2021;volume=12;issue=1;spage=9;epage=13;aulast=

Similar Items